Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Alex, Dulovic"'
Autor:
Manuela Harries, Veronika K. Jaeger, Isti Rodiah, Max J. Hassenstein, Julia Ortmann, Maren Dreier, Isabell von Holt, Melanie Brinkmann, Alex Dulovic, Daniela Gornyk, Olga Hovardovska, Christina Kuczewski, Marc-André Kurosinski, Maike Schlotz, Nicole Schneiderhan-Marra, Monika Strengert, Gérard Krause, Martina Sester, Florian Klein, Astrid Petersmann, André Karch, Berit Lange
Publikováno v:
International Journal of Infectious Diseases, Vol 139, Iss , Pp 50-58 (2024)
Objectives: Throughout the SARS-CoV-2 pandemic, Germany like other countries lacked adaptive population-based panels to monitor the spread of epidemic diseases. Methods: To fill a gap in population-based estimates needed for winter 2022/23 we resampl
Externí odkaz:
https://doaj.org/article/1924d101aa3646c2888835726b894193
Autor:
Judith K. Keller, Alex Dulovic, Jens Gruber, Johanna Griesbaum, Nicole Schneiderhan-Marra, Clemens Wülfing, Jana Kruse, Annika Hartmann, Esther K. Diekhof
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Secretory immunoglobulin A (sIgA) in saliva is the most important immunoglobulin fighting pathogens in the respiratory tract and may thus play a role in preventing SARS-CoV-2 infections. To gain a better understanding of the plasticity in th
Externí odkaz:
https://doaj.org/article/2f59591598714c75a832f04fab1b6ef5
Autor:
Nathalie Verónica Fernández Villalobos, Patrick Marsall, Johanna Carolina Torres Páez, Julia Strömpl, Jens Gruber, Martín Lotto Batista, Daria Pohl, Gustavo Concha, Hagen Frickmann, Fernando Pio de la Hoz Restrepo, Nicole Schneiderhan-Marra, Gérard Krause, Alex Dulovic, Monika Strengert, Simone Kann
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-8 (2023)
Abstract Background Although anti-SARS-CoV-2 humoral immune responses and epidemiology have been extensively studied, data gaps remain for certain populations such as indigenous people or children especially in low- and middle-income countries. To ad
Externí odkaz:
https://doaj.org/article/d90bfb0b882741b1bb98ce5a71eedb75
Autor:
Simon Woelfel, Joel Dütschler, Daniel Junker, Marius König, Georg Leinenkugel, Nicole Graf, Claudia Krieger, Samuel Truniger, Annett Franke, Seraina Koller, Katline Metzger-Peter, Melanie Oberholzer, Nicola Frei, Nora Geissler, Peter Schaub, STAR SIGN Investigators, Werner C. Albrich, Matthias Friedrich, Jan Hendrik Niess, Nicole Schneiderhan-Marra, Alex Dulovic, Wolfgang Korte, Justus J. Bürgi, Stephan Brand
Publikováno v:
Vaccines, Vol 12, Iss 7, p 774 (2024)
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron subvariant XBB.1.5 and are recommended for patients with inflammatory bowel disease (IBD) on immunosuppressive treatment. Nonetheless, their immunogenicity in patients wi
Externí odkaz:
https://doaj.org/article/2fdeebad3bb644b1a2cf47e2eefe19a1
Autor:
Julia Häring, Max J. Hassenstein, Matthias Becker, Julia Ortmann, Daniel Junker, André Karch, Klaus Berger, Tatia Tchitchagua, Olaf Leschnik, Manuela Harries, Daniela Gornyk, Pilar Hernández, Berit Lange, Stefanie Castell, Gérard Krause, Alex Dulovic, Monika Strengert, Nicole Schneiderhan-Marra
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Lyme borreliosis (LB) is the most common tick-borne infectious disease in the northern hemisphere. The diagnosis of LB is usually made by clinical symptoms and subsequently supported by serology. In Europe, a two-step testing cons
Externí odkaz:
https://doaj.org/article/9215cc648a824afab4bfcc0b5a856702
Autor:
Henning Jacobsen, Monika Strengert, Henrike Maaß, Mario Alberto Ynga Durand, Maeva Katzmarzyk, Barbora Kessel, Manuela Harries, Ulfert Rand, Leila Abassi, Yeonsu Kim, Tatjana Lüddecke, Kristin Metzdorf, Pilar Hernandez, Julia Ortmann, Jana-Kristin Heise, Stefanie Castell, Daniela Gornyk, Stephan Glöckner, Vanessa Melhorn, Yvonne Kemmling, Berit Lange, Alex Dulovic, Patrick Marsall, Julia Häring, Daniel Junker, Nicole Schneiderhan-Marra, Markus Hoffmann, Stefan Pöhlmann, Gérard Krause, Luka Cicin-Sain
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract SARS-CoV-2 variants accumulating immune escape mutations provide a significant risk to vaccine-induced protection against infection. The novel variant of concern (VoC) Omicron BA.1 and its sub-lineages have the largest number of amino acid a
Externí odkaz:
https://doaj.org/article/82cbc1d3329f41c08faa87f7a7550462
Autor:
Daniel Junker, Alex Dulovic, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Bjoern Traenkle, Katharina Kienzle, Stefanie Bunk, Carlotta Struemper, Helene Haeberle, Kristina Schmauder, Natalia Ruetalo, Nisar Malek, Karina Althaus, Michael Koeppen, Ulrich Rothbauer, Juliane S. Walz, Michael Schindler, Michael Bitzer, Siri Göpel, Nicole Schneiderhan-Marra
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest in the longevity of immune protection, especially with regard to increasingly infectious virus variants. Neutralizing antibodies (Nabs) targeting the re
Externí odkaz:
https://doaj.org/article/65541620e8964ed78cf2db87bc1b9e1e
Autor:
Alex Dulovic, Monika Strengert, Gema Morillas Ramos, Matthias Becker, Johanna Griesbaum, Daniel Junker, Karsten Lürken, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Anne Cossmann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra, Georg M.N. Behrens
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 4, Pp 743-750 (2022)
Patients undergoing chronic hemodialysis were among the first to receive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations because of their increased risk for severe coronavirus disease and high case-fatality rates. By using a
Externí odkaz:
https://doaj.org/article/bf1f2ba9a9164267856bf376d78e8a99
Autor:
Hanna Renk, Alex Dulovic, Alina Seidel, Matthias Becker, Dorit Fabricius, Maria Zernickel, Daniel Junker, Rüdiger Groß, Janis Müller, Alexander Hilger, Sebastian F. N. Bode, Linus Fritsch, Pauline Frieh, Anneke Haddad, Tessa Görne, Jonathan Remppis, Tina Ganzemueller, Andrea Dietz, Daniela Huzly, Hartmut Hengel, Klaus Kaier, Susanne Weber, Eva-Maria Jacobsen, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Maximilian Stich, Burkhard Tönshoff, Georg F. Hoffmann, Barbara Müller, Carolin Ludwig, Bernd Jahrsdörfer, Hubert Schrezenmeier, Andreas Peter, Sebastian Hörber, Thomas Iftner, Jan Münch, Thomas Stamminger, Hans-Jürgen Groß, Martin Wolkewitz, Corinna Engel, Weimin Liu, Marta Rizzi, Beatrice H. Hahn, Philipp Henneke, Axel R. Franz, Klaus-Michael Debatin, Nicole Schneiderhan-Marra, Ales Janda, Roland Elling
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
In this prospective cohort study, authors follow 328 households in Germany with at least one confirmed SARS-CoV-2 infection and find that children are more likely to seroconvert without symptoms and have higher specific antibody levels that persist l
Externí odkaz:
https://doaj.org/article/af0bd9036d2c4e6cb0fbd39a1d97ce6a
Autor:
Christian Meyer zu Natrup, Alina Tscherne, Christine Dahlke, Malgorzata Ciurkiewicz, Dai-Lun Shin, Anahita Fathi, Cornelius Rohde, Georgia Kalodimou, Sandro Halwe, Leonard Limpinsel, Jan H. Schwarz, Martha Klug, Meral Esen, Nicole Schneiderhan-Marra, Alex Dulovic, Alexandra Kupke, Katrin Brosinski, Sabrina Clever, Lisa-Marie Schünemann, Georg Beythien, Federico Armando, Leonie Mayer, Marie L. Weskamm, Sylvia Jany, Astrid Freudenstein, Tamara Tuchel, Wolfgang Baumgärtner, Peter Kremsner, Rolf Fendel, Marylyn M. Addo, Stephan Becker, Gerd Sutter, Asisa Volz
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 24 (2022)
The SARS-CoV-2 spike (S) glycoprotein is synthesized as a large precursor protein and must be activated by proteolytic cleavage into S1 and S2. A recombinant modified vaccinia virus Ankara (MVA) expressing native, full-length S protein (MVA-SARS-2-S)
Externí odkaz:
https://doaj.org/article/c3dacfdcee5044c4a6d220158af4b33c